Michigan Supreme Court reverses appeals ruling in Lilly insulin pricing case

Lilly's quarterly report says the Michigan Supreme Court in July 2026 reversed a Michigan Court of Appeals decision in the insulin pricing litigation. The filing does not quantify any financial effect from the ruling.

• Michigan Supreme Court reversed the Court of Appeals decision in July 2026
• Insulin pricing litigation disclosed in Lilly's 10-Q
• No change to revenue or guidance was disclosed with the ruling